Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Masamichi Kimura"'
Autor:
Ekumi Kojika, Yutaka Kawakami, Yosuke Osawa, Masamichi Kimura, Hiromi Miyauchi, Tatsuya Kanto, Shigenori Osakaya, Koji Nishikawa, Kiminori Kimura
Publikováno v:
Oncotarget
Scopus-Elsevier
Scopus-Elsevier
Immune checkpoint blockade with specific antibodies can accelerate anti-tumor immunity, resulting in clinical responses in patients with various types of cancer. However, these antibodies achieve only partial tumor regression. Thus, a wide variety of
Autor:
Tatsuya Kanto, Koji Nishikawa, Hiroyoshi Doi, Yukiko K. Hayashi, Kiminori Kimura, Masamichi Kimura, Yosuke Osawa, Sachiyo Yoshio, Ekumi Kojika
Publikováno v:
Hepatology Communications
Hepatocyte apoptosis has been implicated in the progression of nonalcoholic steatohepatitis. However, it is unclear whether the induction of tumor necrosis factor (TNF)-α-mediated hepatocyte apoptosis in the simple fatty liver triggers liver fibrosi
Publikováno v:
Hepatology Research. 48:469-478
Aim Patients with resolved hepatitis B virus (HBV) infection following hematopoietic stem cell transplantation (HSCT) are potentially at high risk of HBV reactivation. Although antiviral drug therapy is recommended when HBV DNA reappears in the serum
Autor:
Yoichi Nakanishi, Kazuaki Inoue, Yosuke Osawa, Koji Todaka, Kenichi Harada, Kiminori Kimura, Tatsuya Kanto, Michinori Kohara, Akemi Ikoma, Masamichi Kimura, Koji Nishikawa, Shinji Shimoda, Maki Shibakawa, Takuji Okusaka, Satoshi Morita, Masashi Mizokami, Masanao Saio, Jun Imamura
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 79-87 (2017)
Background There is currently no anti-fibrotic drug therapy available to treat hepatitis C virus (HCV) cirrhosis. The aim of this study was to assess the safety, tolerability, and anti-fibrotic effect of PRI-724, a small-molecule modulator of Wnt sig